Ali Parsa, Babylon CEO
August 16, 2022 09:12 AM EDT
Financing
Deals

Gos­sip in Baby­lon: Dig­i­tal health com­pa­ny paints M&A ru­mors as flat-out wrong

Kyle LaHucik

Senior Reporter

Baby­lon is re­port­ed­ly con­sid­er­ing a sale or new fi­nanc­ing av­enues in the af­ter­math of a stock slump just quar­ters af­ter go­ing pub­lic via a SPAC …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times